En Es
Categories

Industry News

Canon Medical Systems Initiates Collaborative Research On AI in MR Imaging

By Medimaging International staff writers
05 Apr 2018

Image: Canon Medical Systems has initiated collaborative research on the application of AI-based technology in magnetic resonance imaging (Photo courtesy of iStock).Canon Medical Systems Corporation (Otawara, Tochigi Prefecture, Japan), along with Kumamoto University (Kumamoto Prefecture, Kurokami, Japan) and the University of Bordeaux (Bordeaux, Nouvelle-Aquitaine, France), has initiated collaborative research on the application of Deep Learning Reconstruction (DLR), an Artificial Intelligence (AI)-based technology in magnetic resonance (MR) imaging.

DLR is a reconstruction technology that utilizes deep learning technology to eliminate noise from images. The technology analyzes the relationship between noisy and less noisy images using a computer-generated model, making it possible to eliminate noise from newly acquired images. DLR is capable of acquiring high-resolution images, as well as allowing ultra-high-resolution images to be acquired more quickly in comparison to conventional imaging methods. As a result, the potential applications of this ultra-high-resolution imaging technology in the clinical setting have been attracting significant interest.

Additionally, in comparison to a standard smoothing filter, the noise elimination method employed in DLR causes only a slight reduction in image quality, and signal variation in organ parenchyma is minimized. This improves the image quality and helps to increase accuracy in quantitative analysis, which is easily affected by noise. Hence, DLR is considered as a major technological advance that can dramatically change how MRI examinations will be performed in the future. The combination of the latest AI technology with next-generation MRI scanners is expected to be useful in eliminating noise and improving image quality, as well as in a wide variety of MR-related fields.

“DLR has the potential to transform the conventional concept of MR imaging and is expected to allow the acquisition of super-high-resolution images in a shorter time and contribute to more accurate quantitative analysis,” said Professor Yasuyuki Yamashita of the Department of Diagnostic Radiology, Faculty of Life Science, Kumamoto University.

“When DLR is used in combination, the ultra-high-resolution images acquired using the latest 3-T MRI system from Canon Medical Systems (installed last November) are comparable to images acquired using a 7-T MRI system. This suggests that DLR may be able to take the place of some high-field conventional MRI studies,” added Professor Vincent Dousset, Institut de Bio-Imagerie Université de Bordeaux, Chef de Service Neuro-Imagerie CHU de Bordeaux.

“We are very proud to have started this cutting-edge collaborative research which will lead to the development of next-generation MRI technology at leading medical institutions both in and outside Japan. We anticipate that this research will prove to be of great value by providing higher-resolution images for clinical diagnosis,” said President Takiguchi of Canon Medical Systems Corporation.



E-mail Print
FaceBook Twitter Google+ Linked in

CANON

Canon U.S.A., Inc. provides digital imaging solutions for the healthcare sector, including digital detectors, digital radiography / fluoroscopy solutions, mobile & portable solutions, acquisition carts, and software solutions.
More info

More articles about CANON

09 Jan 2018
Toshiba Medical Systems Changes Name to Canon Medical Systems
The official corporate name of Toshiba Medical Systems Corporation has been changed to Canon Medical Systems Corporation. The name change follows the completion of procedures for obtaining regulatory approval for integration with the Canon Group after the company officially became a subsidiary of Canon Inc. in December 2016. Similarly, Toshiba America Medical Systems, now a Canon group company, has been officially named as Canon Medical Systems USA, Inc.
Read More
22 Dec 2016
Canon Completes Acquisition of Toshiba Medical
Japanese electronics manufacturer Canon Inc. has completed its acquisition of Toshiba Medical Systems Corp., a medical unit of Toshiba Corp. that provides medical imaging products and solutions. Canon has received the necessary clearance from competition regulatory authorities to make Toshiba Medical its subsidiary in a USD 54.7 billion deal.
Read More

Additional news

24 Apr 2018
Fujifilm Showcases Extended Product Line at ECR 2018
Fujifilm Medical Systems Europe, a provider of diagnostic imaging products and medical informatics solutions, showcased its broad, enhanced line up of products and solutions at the European Congress of Radiology (ECR) 2018. The products and solutions showcased by Fujifilm at ECR 2018 focused on women’s health, healthcare IT, artificial intelligence (AI), digital radiography (DR), computed tomography (CT), computed radiography and ultrasound.
Read More
24 Apr 2018
AI Device for Diabetic Retinopathy Receives FDA Approval
The first-ever medical device to use artificial intelligence (AI) for detecting diabetic retinopathy has received marketing approval from the US Food and Drug Administration (FDA). The AI-based diagnostic system named IDx-DR, which has been developed by privately-held AI diagnostics company IDx, is the first device to be authorized for marketing that provides a screening decision without the need for a clinician to also interpret the image or results. This means that the device can also be used by health care providers who may not normally be involved in eye care.
Read More
24 Apr 2018
AI-Based Platform Designed to Classify Strokes Quickly
An artificial intelligence (AI)-based stroke diagnosis platform designed to assist doctors in quickly classifying the cause of a stroke has completed clinical trials and is expected to provide key information to determine treatment for stroke, leading to faster and more-precise decision-making for patients.
Read More
24 Apr 2018
Breast Density Assessment Software Receives FDA Clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to a machine learning breast density assessment software that empowers radiologists with standardized, personalized and automated density reports to optimize women’s breast health and follow-up care decisions. The software is now cleared for clinical use in the US, Europe, Canada and Australia, and is the first of several follow-on products to be launched by Densitas Inc., a developer of breast imaging analytics.
Read More
19 Apr 2018
Seegene Unveils Combination Test at ECCMID 2018
Seegene Inc., a developer of multiplex PCR technologies, introduced a combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) held in Madrid, Spain, from April 21 to 24, 2018. The combination test is a high-efficiency solution that diagnoses various causes of diseases with multiplex molecular diagnosis assays. Seegene also showcased its molecular diagnostic system SGSTAR (Seegene Sameday Test and Report), which allows order-to-report on the same day and enables the running of the combination test.
Read More
18 Apr 2018
Breast Imaging Market Worth USD 7 Billion by 2024
The global breast imaging market size was estimated at USD 2.9 billion in 2016 and is expected to reach USD 7.3 billion by 2024, driven by the increasing prevalence of breast cancer and other breast-related diseases such as infections, lesions and fibrocysts, as well as supportive government initiatives to increase awareness.
Read More
17 Apr 2018
Veritas Capital Acquires IT Unit of GE Healthcare
Veritas Capital, a private equity investment firm, has entered into a definitive agreement with General Electric, to acquire the Enterprise Financial Management (Revenue-Cycle, Centricity Business), Ambulatory Care Management (Centricity Practice Solution) and Workforce Management (formerly API Healthcare) assets comprising GE Healthcare’s Value-Based Care Division for USD 1.05 billion in cash.
Read More
16 Apr 2018
Interactive VR Assists in Treatment Planning
Interactive virtual reality (VR) shows a patient's unique internal anatomy to interventional radiologists in order to help physicians effectively prepare and tailor their approach to complex treatments, such as splenic artery aneurysm repair. In a new study, researchers compared the VR technology to the use of images from a commonly used visualization software system that displays images on a standard two-dimensional platform and found the accuracy to be similar with both methods, though confidence improved substantially with VR.
Read More
05 Apr 2018
New AI Technique Dramatically Improves Quality of Medical Imaging
Researchers have developed a new technique based on artificial intelligence (AI) and machine learning that enables radiologists to acquire higher quality images without having to collect additional data at the cost of increased radiation dose for computed tomography (CT) and positron emission tomography (PET) or uncomfortably long scan times for magnetic resonance imaging (MRI).
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions